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the cartilage and bone compartments of the implanted construct, 
it is well-suited to delivery of different concentrations of growth 
factor (or, to deliver two different facors) to the bone and cartilage 
regions. 
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Introduction: Interleukin-ll~ (IL-11~) is known to induce the re- 
lease of both nitric oxide (.NO) and prostaglandin E2 (PGE2) in ar- 
ticular chondrocytes, a response reversed with the application of 
dynamic compression. IL-11~ has also been shown to activate all 
three members of the mitogen activated protein kinase (MAPK) 
family, namely JNK, p38 and ERK. However, the role of the MAPK 
subtypes in the release of .NO and PGE2 in IL-11~ stimulated 
chondrocytes is complex and may primarily involve phosphory- 
lation of p38 MAPK, JNK and activation of transcription factors, 
NFKB and AP-1. The current study examines whether inhibition 
of these pathways can influence .NO and PGE2 release in IL-11~ 
stimulated bovine chondrocytes cultured in agarose constructs 
and subjected to dynamic compression. 
Methods: Bovine chondrocytes were seeded in agarose gel and 
equilibrated in culture for 24 hours. Constructs were cultured un- 
der free-swelling conditions, for a further 48 hours in medium con- 
taining 0 or 10 ng.ml-llL-11~ either in the presence and absence 
of 0 to 1000 ng.ml- 1 SB203580 (inhibitor of p38 MAPK) or 0 to 50 
nM JNK II (inhibitor of c-Jun N-terminal kinase for JNK-1, JNK-2 
and JNK-3), or 0 to 1000 ng.m1-1 PDTC (inhibits NFKB activa- 
tion) or 0 to 1000 ng.m1-1 Curcumin (inhibitor of AP-1). For the 
mechanical loading experiments, all constructs were subjected to 
15% dynamic compressive strain at 1 Hz frequency for 48 hours 
in medium supplemented with 0 or 10 ng.ml-llL-11 ~in the pres- 
ence and absence of 10 ng.ml-lSB203580 or 5 nM JNK II or 10 
ng.ml-1PDTC or 10 ng.ml-lCurcumin. Nitrite, a stable end prod- 
uct of .NO, was measured using the Griess assay. PGE2 release 
was measured using an enzyme immunoassay. 
Results: SB203580 and JNK II resulted in the dose-dependent 
inhibition of nitrite and PGE2 release in IL-11~ stimulated con- 
structs cultured under free-swelling conditions, at concentrations 
ranging from 0 to 1000 ng.m1-1 and 0 to 50 nM, respectively. 
Both PDTC and Curcumin reversed the IL-11~ induced nitrite at 
all inhibitor concentrations, whereas PGE2 levels were only par- 
tially inhibited in the presence of PDTC or Curcumin. For the dy- 
namic loading experiments, strain-induced inhibition of nitrite was 
enhanced by the presence of IL-11~. The compression-induced 
inhibition of nitrite in the presence of IL-11~ was abolished by 
SB203580, PDTC and Curcumin and partially reduced by JNK II. 
PGE2 levels were not significantly influenced by dynamic com- 
pression in unsupplemented constructs. IL-11~ significantly en- 
hanced strain-induced inhibition of PGE2 release. This effect was 
abolished by SB203580 and JNK II and partially reduced by 
PDTC and Curcumin. 
Discussion: These results suggest the involvement of MAPKs, 
AP-1 and NFKB transcription factors in the IL-11~ induced release 
of .NO and PGE2. Further work will determine the sequential acti- 
vation of the signalling cascades associated with mechanical load 
and IL-11~. Moreover, the temporal organization of the multiple 
pathways will provide important information for the pharmacolog- 
ical and biophysical treatment of degenerative joint disease. 
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Aim of Study: Joint impact injuries are known to increase the 
risk of development of secondary osteoarthritis. The proinflam- 
matory mediator, prostaglandin E2 (PGE2), is synthesised from 
arachidonic acid by cyclooxygenase-2 (COX-2) and is elevated in 
articular cartilage and synovial fluid in osteoarthritic joints. This 
study investigated the release of PGE2 from cartilage following 
an impact load and the possible chondroprotective effect of COX- 
2 inhibition using nonsteroidal anti-inflammatory drugs (NSAIDs). 
Methods: Full depth, circular explants (5 mm diameter) of articu- 
lar cartilage were removed from the underlying subchondral bone 
of human femoral heads (n=3) using a cork borer and scalpel and 
cultured for 72 h. The explants were then subjected to a single im- 
pact load using a 500 g mass dropped from a height of 25 mm in a 
drop tower. The duration of each impact was approximately 3 ms 
with an energy of 0.13 J. Following impact, the loaded explants 
were cultured along with unloaded controls for 3 and 6 days, in the 
presence of either a selective COX-2 inhibitor, celecoxib, (0.01, 
0.1, 1.0 and 10 I~M) or indomethacin (0.1 and 10 I~M) which is 
nonselective and inhibits both COX-1 and COX-2. The explants 
(n _>11 in each treatment group) were then removed, frozen in 
liquid nitrogen and stored with their culture medium at -20°C. 
PGE2 was measured in the explant culture medium by ELISA. 
The concentration of glycosaminoglycans (GAGs), a measure of 
cartilage breakdown, was determined in the culture medium us- 
ing the dimethylmethylene blue (DMMB) assay. 
Results: PGE2 levels were increased more than 20 fold 
(P<0.001) in the medium of explants at both 3 and 6 days fol- 
lowing impact compared to unloaded controls. In the presence of 
celecoxib and indomethacin the PGE2 levels were reduced in a 
dose related manner, and at the highest concentration (10 I~M) 
the levels were reduced to those of the unloaded controls by both 
inhibitors. The concentration of GAGs in the medium was signif- 
icantly higher (P<0.001) in the loaded explants compared to un- 
loaded controls at both 3 and 6 days following impact. However 
the addition of celecoxib or indomethacin to the culture medium 
had no effect in reducing the release of GAGs from the cartilage 
matrix. 
Conclusions: In this study, a marked increase in PGE2 was 
measured in the medium following an impact load in articular 
cartilage. This increase was abolished with both the selective 
COX-2 inhibitor, celecoxib, and nonselective indomethacin. No 
change was observed in the release of GAGs from the explants 
in the presence of these inhibitors, however, suggesting that the 
COX/PGE2 pathway is not directly responsible for cartilage break- 
down following impact injury. 
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Aim of study: The aim of this study was to determine the ef- 
